Clinical Trial Update: TNFerade™ Biologic Plus Radiation for Metastatic Melanoma [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial update evaluating TNFerade Biologic in combination with radiation for metastatic melanoma; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• TNFerade Biologic (TNFerade)

Snippet

Sponsor: GenVec | Conditions: Melanoma | Phase 2 | Status: COMPLETED